Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis.

Br J Cancer · 2009 · PMC2768450 · PMID 19773751

Europe PMC DOI

hedged sentences

0.0970

closest p · 1.9× alpha

0.0970

boldest claim

The sentences

showed a trendP =0.097so close (0.05 < p ≤ 0.1)

A corresponding subgroup analysis within colon cancer stage III patients showed a trend for improved RFS with high EZH2 index ( P =0.097), whereas a similar analysis for CSS was not significant ( P =0.14; Figure 3 , panels C and D).

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Subgroup analyses showed that this benefit was primarily in patients with colon cancer stage III, but this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.